QuidelOrtho is a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems. The company's brand names include Sofia(R), Solana(R), Lyra(R), Triage(R) and QuickVue(R). Its comprehensive product portfolio includes tests for a range of infectious diseases, cardiac and autoimmune biomarkers, as well as a host of products to detect COVID-19. QuidelOrtho, formerly known as Quidel Corporation, is based in SAN DIEGO.
Revenue (Most Recent Fiscal Year) | $2.78B |
Net Income (Most Recent Fiscal Year) | $-2.05B |
PE Ratio (Current Year Earnings Estimate) | 10.09 |
PE Ratio (Trailing 12 Months) | 10.22 |
PEG Ratio (Long Term Growth Estimate) | -- |
Price to Sales Ratio (Trailing 12 Months) | 0.59 |
Price to Book Ratio (Most Recent Quarterly Book Value per Share) | 0.58 |
Price to Cash Ratio (Most Recent Annual Cash Flow per Share) | 0.67 |
Pre-Tax Margin (Trailing 12 Months) | -14.89% |
Net Margin (Trailing 12 Months) | -16.10% |
Return on Equity (Trailing 12 Months) | 5.29% |
Return on Assets (Trailing 12 Months) | 2.43% |
Current Ratio (Most Recent Fiscal Quarter) | 1.12 |
Quick Ratio (Most Recent Fiscal Quarter) | 0.66 |
Debt to Common Equity (Most Recent Fiscal Quarter) | 0.74 |
Inventory Turnover (Trailing 12 Months) | 2.57 |
Book Value per Share (Most Recent Fiscal Quarter) | $41.13 |
Earnings per Share (Most Recent Fiscal Quarter) | $0.12 |
Earnings per Share (Most Recent Fiscal Year) | $1.77 |
Diluted Earnings per Share (Trailing 12 Months) | $-6.54 |
Exchange | NASDAQ |
Sector | Healthcare |
Industry | Medical Devices |
Common Shares Outstanding | 67.90M |
Free Float | 67.36M |
Market Capitalization | $1.62B |
Average Volume (Last 20 Days) | 1.61M |
Beta (Past 60 Months) | -0.04 |
Percentage Held By Insiders (Latest Annual Proxy Report) | 0.79% |
Percentage Held By Institutions (Latest 13F Reports) | 99.00% |
Annual Dividend (Based on Last Quarter) | $0.00 |
Dividend Yield (Based on Last Quarter) | 0.00% |